Mack Brown Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.14 M
- Company Age 41 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 Cr
- Revenue Growth %
- Net Worth 4.46%
- Total Assets 18.41%
About Mack Brown Pharmaceuticals
Mack Brown Pharmaceuticals Pvt Ltd (MBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 1983 and has a history of 41 years and ten months. Its registered office is in Chandigarh, India.
The Company is engaged in the Consumer Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹2.60 Cr.
Revati Devi, Kulbhushan Kant, Vaibhav Pokhriyal, and One other member serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232CH1983PTC005351
-
Company No.
005351
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 1983
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Mack Brown Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kulbhushan Kant
|
Managing Director | 21-Mar-1983 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Revati Devi
|
Director | 03-Jul-1992 | Current |
|
Vaibhav Pokhriyal
|
Director | 10-Dec-2010 | Current |
|
Sushma Sharma
|
Director | 29-Mar-2023 | Current |
Financial Performance of Mack Brown Pharmaceuticals.
Mack Brown Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mack Brown Pharmaceuticals?
In 2019, Mack Brown Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹26.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2021 | Hdfc Bank Limited | ₹6.00 M | Open |
| 10 Mar 2017 | Hdfc Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Mack Brown Pharmaceuticals?
Unlock and access historical data on people associated with Mack Brown Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mack Brown Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mack Brown Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.